Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiun Hsu

Showing results (71-80 of 191) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionChiun Hsu, Liang-In Lin, Yu-Che Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 11, 2019
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patientsShih-Hung Yang, Jhe-Cyuan Guo, Chiun Hsu, et al.
Molecular Cancer|January 7, 2014
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivinDa-Liang Ou, Bin-Shyun Lee, Liang-In Lin, et al.
Cancers|January 21, 2022
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in CancerChing-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, et al.
Oncology|October 26, 2011
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trialsShih-Hung Yang, Yu-Hsuan Kuo, Yu-Wen Tien, et al.
World Journal of Gastroenterology|May 8, 2014
Hepatitis B and C viruses are not risks for pancreatic adenocarcinomaMing-Chu Chang, Chien-Hung Chen, Ja-Der Liang, et al.
International Journal of Medical Informatics|March 25, 2026
A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validationChiao-Chi Kuan, Jhe-Cyuan Guo, Shan-Hsiang Shen, et al.
Plos One|July 3, 2013
Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathwayDa-Liang Ou, Bin-Shyun Lee, Ya-Chi Chang, et al.
Cancer Research and Treatment|May 21, 2015
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic ReviewJoon Oh Park, Do-Youn Oh, Chiun Hsu, et al.
British Journal of Cancer|March 3, 2022
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinomaYu-Yun Shao, Pai-Sheng Chen, Liang-In Lin, et al.
Pageof 20

Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2015
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionChiun Hsu, Liang-In Lin, Yu-Che Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 11, 2019
Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patientsShih-Hung Yang, Jhe-Cyuan Guo, Chiun Hsu, et al.
Molecular Cancer|January 7, 2014
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivinDa-Liang Ou, Bin-Shyun Lee, Liang-In Lin, et al.
Cancers|January 21, 2022
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in CancerChing-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, et al.
Oncology|October 26, 2011
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trialsShih-Hung Yang, Yu-Hsuan Kuo, Yu-Wen Tien, et al.
World Journal of Gastroenterology|May 8, 2014
Hepatitis B and C viruses are not risks for pancreatic adenocarcinomaMing-Chu Chang, Chien-Hung Chen, Ja-Der Liang, et al.
International Journal of Medical Informatics|March 25, 2026
A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validationChiao-Chi Kuan, Jhe-Cyuan Guo, Shan-Hsiang Shen, et al.
Plos One|July 3, 2013
Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathwayDa-Liang Ou, Bin-Shyun Lee, Ya-Chi Chang, et al.
Cancer Research and Treatment|May 21, 2015
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic ReviewJoon Oh Park, Do-Youn Oh, Chiun Hsu, et al.
British Journal of Cancer|March 3, 2022
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinomaYu-Yun Shao, Pai-Sheng Chen, Liang-In Lin, et al.
Pageof 20